STERIS Consumables — Revenue increased by 2.6% to $463.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 8.5%, from $426.90M to $463.00M. Over 3 years (FY 2022 to FY 2025), Consumables — Revenue shows an upward trend with a 18.8% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
An increase indicates higher utilization of the company's installed equipment base or expanded market penetration for recurring supplies, while a decrease may signal reduced procedure volumes or competitive pressure.
This metric represents the total net sales generated from the sale of recurring, single-use products and supplies essent...
Comparable to 'Recurring Revenue' or 'Consumables and Disposables' segments in medical device and life sciences companies, where revenue is tied to procedure volume rather than capital equipment sales.
ste_segment_consumables_revenues| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $263.23M | $331.84M | $334.85M | $74.69M | $311.59M | $303.47M | $315.42M | $360.95M | $341.98M | $365.43M | $389.51M | $403.08M | $413.20M | $413.80M | $426.90M | $428.79M | $434.20M | $451.40M | $463.00M |
| QoQ Change | — | +26.1% | +0.9% | -77.7% | +317.2% | -2.6% | +3.9% | +14.4% | -5.3% | +6.9% | +6.6% | +3.5% | +2.5% | +0.1% | +3.2% | +0.4% | +1.3% | +4.0% | +2.6% |
| YoY Change | — | — | — | — | +18.4% | -8.5% | -5.8% | +383.2% | +9.8% | +20.4% | +23.5% | +11.7% | +20.8% | +13.2% | +9.6% | +6.4% | +5.1% | +9.1% | +8.5% |